DeutschNewstral
Article
jdsupra.com on 2015-03-09 14:18
FDA Approves Sandoz Filgrastim Biosimilar
Related news
- FDA Approves Sandoz Biosimilar for Tysabri®jdsupra.com
FDA Approves Rheumatoid Arthritis Biosimilarwsj.com- FDA Approves First Biosimilar Drugwsj.com
- FDA Approves Sandoz’s Biosimilar Pegfilgrastimjdsupra.com
- FDA Approves Yet Another Interchangeable Biosimilar and Another Biosimilarjdsupra.com
- FDA Approves Samsung Bioepis’s Trastuzamab Biosimilarjdsupra.com
- FDA approves a fourth biosimilar of HERCEPTINjdsupra.com
- FDA Approves Coherus’ Adalimumab Biosimilar YUSIMRY™jdsupra.com
- FDA Approves 25th Biosimilarjdsupra.com
- FDA Approves First Cancer-Treatment Biosimilar -- Amgen's Mvasijdsupra.com
- FDA Accepts Applications for Rituximab and Filgrastim Biosimilar Candidatesjdsupra.com
- Sandoz Obtains FDA Approval for Adalimumab Biosimilarjdsupra.com
- FDA Approves Ogivri, Mylan’s Biosimilar Version of Herceptinjdsupra.com
- Breaking News: FDA Approves Samsung Bioepis’s Biosimilar of REMICADE®jdsupra.com
- FDA Approves Third Biosimilar Productjdsupra.com
- FDA Approves Sandoz Denosumab Biosimilarsjdsupra.com
- FDA Approves First Avastin Biosimilarjdsupra.com
- FDA Approves First Rituximab Biosimilarjdsupra.com
- FDA Approves Another Interchangeable Biosimilarjdsupra.com
- FDA Approves Lantus® Interchangeable Biosimilarjdsupra.com